Published: September 2025 | Last updated: May 2026
Donovanosis is rare in the United States, but the path to a correct diagnosis follows the same painful loop people walk for far more common sexual-health concerns: weeks of the wrong creams, dismissive visits, and a sore that keeps changing while clinicians look for something more familiar. This guide explains what Donovanosis actually looks like, why it gets confused with herpes or staph, what to ask for at your appointment, and how to push back when your provider has never heard of Klebsiella granulomatis.
It Didn't Hurt, So Why Would I Think It's an STD?
One feature throws people off most about Donovanosis: it does not hurt. There is no burning, no fever, no throbbing. People who have had herpes describe Donovanosis as feeling completely different. The sore opens, expands, and starts bleeding on contact, but it does all of that quietly over weeks. That muted presentation is the reason most people wait too long to see a doctor, and the reason most doctors look for something else when they finally do.
The early lesion typically appears as a single red bump or nodule. Some describe it as soft and raised, with a slightly shiny or velvety surface. Over time, that bump ulcerates. It slowly expands into a beefy red sore with rolled, well-defined edges. The inside of the ulcer often looks moist and granular. The wound bleeds easily, especially during sex or even from simple friction while walking. None of this is intuitive. In the moment, most people just think: weird, but not alarming.
A Donovanosis bump can sit for weeks looking like a shaving nick, an ingrown hair, or an insect bite. Painless slow growth is precisely the feature that gets it dismissed at first contact, and the same feature that explains why most people only seek care once the ulcer has already expanded.
Why Donovanosis Keeps Getting Missed in the U.S.
Most U.S. doctors have never seen a single case of Donovanosis. It barely comes up in medical school. It is not part of routine STI panels, urgent care triage, or commercial laboratory NAAT batteries. When a patient walks in with a painless genital sore, providers look for what they actually see in their clinic week to week: herpes, syphilis, bacterial vaginosis, infected hair follicles, fungal rashes, allergic reactions.
Diagnostic infrastructure mirrors this gap. No FDA-cleared PCR test exists for Klebsiella granulomatis in the United States. Most confirmed diagnoses come from a tissue smear stained with Wright-Giemsa or Warthin-Starry, examined under microscope for the characteristic intracellular Donovan bodies (CDC STI treatment guidelines). In rural areas and busy metro clinics alike, that workflow is rarely available. Without the biopsy, most cases default to clinical appearance plus a process of elimination, which usually means: acyclovir for presumed herpes, doxycycline for presumed chancroid, antifungals, then steroids. By the time someone in the chain says "wait, what if this is something rarer," the ulcer has been quietly expanding for months.
There is no FDA-cleared PCR test for Klebsiella granulomatis in the United States. Confirmed diagnosis requires a tissue smear from the ulcer edge, stained with Wright-Giemsa or Warthin-Starry, and examined under microscope for Donovan bodies. If a clinician says "we tested for everything," that almost certainly does not include Donovanosis.
How Donovanosis Compares to the Conditions It Gets Confused With
Visual overlap is the main reason for misdiagnosis. A red bump or genital sore could be a shaving nick, an ingrown hair, chancroid, herpes, primary syphilis, fixed drug eruption, or an allergic reaction. What distinguishes Donovanosis is how the lesion evolves over weeks, rather than how it looks on day one. Painless, slow-growing, easily bleeding ulcers with rolled edges narrow the differential significantly, but only if a provider knows to look.
| Condition | Pain Level | Appearance | Healing Pattern |
|---|---|---|---|
| Donovanosis | Usually painless | Beefy red ulcer, rolled edges, bleeds easily | Spreads slowly without treatment |
| Herpes (HSV) | Moderate to severe pain | Grouped vesicles, blisters, crusting | Heals in 1 to 2 weeks, recurs periodically |
| Primary syphilis | Usually painless | Firm, round chancre with clean base | Heals within 3 to 6 weeks, even without treatment |
| Staph / MRSA | Often tender or painful | Pustules, boils, abscesses | May drain pus, responds to antibiotics |
| Chancroid | Painful | Soft ulcer with ragged edges, undermined | Spreads if untreated, often tender lymph nodes |
What does Donovanosis actually look like?
Donovanosis usually starts as a small painless red bump on the genitals, perineum, or inner thigh. Over weeks, the bump becomes a beefy red ulcer with rolled edges that bleeds easily on contact. It does not crust, scab, or recur the way herpes does, and it will not heal on its own. Symptoms appear roughly 1 to 12 weeks after exposure, sometimes longer.
Patterns of Delay: How Misdiagnosis Plays Out
Case reports of Donovanosis in U.S. and European patients share a consistent timeline. A painless sore appears one to twelve weeks after exposure. The person waits another two to four weeks before seeking care, often blaming friction from clothing or recent shaving. The first clinician evaluates for herpes, tests negative, and prescribes valacyclovir empirically. The sore continues to grow. A second visit produces a presumed diagnosis of chancroid, MRSA, or fungal infection. Antibiotics and antifungals are tried in sequence. By the time someone considers a biopsy, the lesion may be several centimeters across and bleeding visibly on contact.
The longer Donovanosis goes untreated, the more tissue it consumes. Klebsiella granulomatis multiplies inside macrophages, which is why the dermis is invaded slowly but relentlessly. Treatment must continue until the wound is fully re-epithelialized, not just "looking better." Early antibiotic intervention typically resolves the infection without scarring. Late intervention can require surgical management for extensive tissue destruction (NCBI clinical overview).
Three weeks of antibiotics is the floor, not the finish line. Treatment continues until a provider confirms full wound closure, not just when the sore visually improves. Patients who stop early are the same patients who come back six months later with relapse at the original site, sometimes more extensive than the first episode.
Treatment That Works, When It Is the Right One
Donovanosis is curable with antibiotics, provided the right antibiotic at the right duration follows a correct identification of the infection. The CDC sexually transmitted infections treatment guidance recommends azithromycin as first-line: either 1 gram orally once weekly, or 500 milligrams orally daily, continued for at least 3 weeks and until all lesions have completely healed. Alternative regimens listed in the 2021 CDC guidelines are doxycycline, erythromycin base, or trimethoprim-sulfamethoxazole, also continued until healing is complete.
Most patients are not warned about the duration. Five days of antibiotics is not enough. Three weeks is the floor. Some cases require six to eight weeks of continuous therapy, with follow-up to confirm re-epithelialization and check for relapse. Patients who stop early because the lesion "looks better" are the patients who come back six months later with recurrence at the original site, sometimes more extensive than before.
| Medication | Dosage | Duration | Notes |
|---|---|---|---|
| Azithromycin | 500 mg daily or 1 g weekly | Minimum 3 weeks, until full healing | Preferred regimen per CDC 2021 guidance |
| Doxycycline | 100 mg twice daily | 3+ weeks, until full healing | Contraindicated in pregnancy |
| Erythromycin base | 500 mg four times daily | 3+ weeks, until full healing | Preferred in pregnancy; GI side effects common |
| Trimethoprim-sulfamethoxazole | One double-strength tablet (160/800 mg) twice daily | 3+ weeks, until full healing | Not recommended in pregnancy; useful when doxycycline and erythromycin are contraindicated |
The Emotional Toll of Being Misdiagnosed Repeatedly
Misdiagnosis is more than a delay in treatment. People who have walked this path describe a slow erosion of trust in their own perception. After the second or third visit produces another prescription that does nothing, the conclusion is often internal: maybe this is my fault, maybe I am overreacting, maybe I should stop bothering people. That self-doubt is the most common reason patients give for waiting weeks longer before seeking a fourth opinion, the one that finally results in a biopsy.
Medical-research literature has a name for this pattern: epistemic injustice, the systematic dismissal of a patient's testimony about their own body. It is well-documented in sexual-health settings, and disproportionately affects women, people of color, and patients without insurance. Donovanosis is unusually well-suited to trigger it, because the condition is rare enough that most providers feel safe ruling it out without testing, and the lesion is intimate enough that patients feel embarrassed pushing back.
Bring photographs of the lesion's progression, a written symptom timeline, and the specific terms "Donovanosis," "granuloma inguinale," and "Klebsiella granulomatis" to your next visit. Naming the condition and the bacterium changes the conversation from open-ended evaluation into a specific diagnostic request.
How to Self-Advocate When Something Is Not Adding Up
If a sore is not healing on the treatment you have been given, and your second or third provider is still hedging without ordering a biopsy, that combination is clinical data. Your next reasonable step is a tissue biopsy or smear from the ulcer edge, examined for Donovan bodies. You can ask for this directly, naming Donovanosis and Klebsiella granulomatis. You can also ask for a referral to an infectious-disease specialist or a sexual-health clinic. Neither request is unreasonable.
You can additionally rule out the look-alikes with at-home testing. Running a rapid panel for herpes, syphilis, HIV, chlamydia, and gonorrhea will return a clean result if Donovanosis is the actual cause. That documented panel gives your next provider a clearer starting point for the biopsy conversation.
Use the condition name (Donovanosis or granuloma inguinale). Use the bacterium name (Klebsiella granulomatis). Use the test request: "a tissue smear or biopsy from the ulcer edge, stained for Donovan bodies." Saying all three signals to a provider that you are asking for a specific differential, not a general workup.
Donovanosis in the U.S.: Less Foreign Than the Textbooks Suggest
Donovanosis is still classified as rare in the United States. The U.S. Centers for Disease Control and Prevention stopped tracking it as a separately reportable condition years ago. It now occupies a kind of surveillance blind spot: mentioned in treatment guidelines, but not actively monitored. Most diagnoses are confirmed only after other conditions have been ruled out, and many cases are never formally confirmed at all because the necessary tissue work is not done.
Case reports published over the last decade describe scattered U.S. diagnoses, including patients with no overseas travel history. Patients in these reports had previously been labeled with herpes, MRSA, or fungal infections before tissue smears revealed Klebsiella granulomatis. The authors generally emphasize that their cases are almost certainly the visible portion of a larger underdiagnosed group, particularly in underserved communities where biopsy is not the default workflow for an unexplained genital ulcer.
Travel history raises the likelihood. India, Papua New Guinea, parts of the Caribbean, southern Africa, and northern South America remain higher-prevalence regions (Cleveland Clinic overview). The absence of travel does not rule it out. Providers who do not consider Donovanosis will not find it, regardless of their patient's travel history.
The lesions are highly vascular (i.e., beefy red appearance) and can bleed.
Stages of Donovanosis and What Each One Means
Donovanosis progresses through reasonably predictable stages, which is both a clinical advantage and a missed-opportunity story. Each stage offers a chance to intervene earlier than the previous one, and each stage corresponds to a typical wrong diagnosis at that point in the timeline. The table below is the simplified version of what clinicians who actually work with this condition look for.
| Stage | Appearance | Common Mistake | What to Do |
|---|---|---|---|
| Early nodule | Red bump, painless, no drainage | Bug bite, ingrown hair, friction rash | Monitor closely; if no change in 1 week, seek care |
| Ulceration begins | Soft open sore, may bleed with friction | Herpes, fungal infection, eczema | Request full STD panel and clinical evaluation |
| Advanced lesion | Beefy red ulcer with rolled edges, growing | Syphilis, MRSA, cancerous lesion | Ask for biopsy, smear test, infectious-disease referral |
| Post-treatment phase | Scarring, discoloration, tissue change | Assumed healed infection | Continue follow-up; check for recurrence every 6 to 12 months |
What Testing Actually Looks Like
Donovanosis will not appear on a routine STD panel. It will not show up in urine, blood, or swab specimens collected for chlamydia, gonorrhea, syphilis, or herpes. Diagnosis remains a tissue sample from the edge of the ulcer, smeared on a slide, stained with Wright-Giemsa or Warthin-Starry stain, and examined under microscope for Donovan bodies, the characteristic intracellular bacteria that gave the infection its name.
Some specialized laboratories now offer PCR testing for Klebsiella granulomatis as a research tool, but there is no FDA-cleared commercial PCR test in the United States. If a provider tells you "we tested for everything," that is almost certainly not true for Donovanosis. Ask for it by name: "Can we biopsy the ulcer edge and stain for Donovan bodies?" Asking that specific question converts an open-ended evaluation into a specific diagnostic request.
Three specific terms get a workup moving: the condition name (Donovanosis or granuloma inguinale), the bacterium (Klebsiella granulomatis), and the test request (tissue smear or biopsy from the ulcer edge, stained for Donovan bodies). If your provider remains uncertain after that, ask for a referral to an infectious-disease specialist or a sexual-health clinic.
Frequently Asked Questions
- Can an STD really look like a bug bite?
- Yes. Donovanosis often starts as a small painless red bump that looks like a mosquito bite, an ingrown hair, or a shaving nick. The difference shows up over weeks: a bug bite fades, while a Donovanosis bump quietly ulcerates and starts bleeding on contact. If a "bite" is still there after two to three weeks and changing, it is worth a clinical visit.
- Is Donovanosis painful?
- Usually not. That is what throws most people off. It does not burn like herpes or throb like an abscess. The sore just exists, expanding slowly. Painless and quiet, which makes it easy to ignore until it starts bleeding or spreading.
- How long after exposure do symptoms appear?
- Anywhere from one to twelve weeks. Some people develop visible lesions much later, which can make tracing the source difficult. The absence of an immediate symptom does not mean nothing is happening; the bacteria can multiply in skin macrophages for weeks before visible ulceration begins.
- Will Donovanosis show up on a standard STD test?
- No. Routine STD panels test for chlamydia, gonorrhea, syphilis, herpes, HIV, and hepatitis. Donovanosis requires a tissue smear or biopsy from the ulcer edge, stained and examined under microscope for Donovan bodies. There is no FDA-cleared PCR test for it in the United States.
- What should I say if my provider has never heard of Donovanosis?
- Use specific words. Name the condition: Donovanosis or granuloma inguinale. Name the bacteria: Klebsiella granulomatis. Name the test: biopsy or smear from the ulcer edge stained for Donovan bodies. If the provider remains uncertain, ask for a referral to an infectious-disease specialist or sexual-health clinic.
- Can Donovanosis come back after treatment?
- Yes. Recurrence can happen, especially within the first six to eighteen months after treatment. Do not stop antibiotics just because the sore looks healed; continue until your provider confirms full re-epithelialization. Periodic check-ins afterward let you catch a relapse early if it happens.
- Is Donovanosis only found in certain countries?
- It is more common in India, Papua New Guinea, parts of the Caribbean, southern Africa, and northern South America. But cases continue to be diagnosed in U.S. patients with no overseas travel history. Travel raises the likelihood; the absence of travel does not rule it out.
- What is the standard treatment?
- Azithromycin is the standard choice, taken daily or once weekly depending on tolerability. The critical detail most patients are not told: three weeks is the minimum, and the course continues until a provider confirms full wound closure rather than ending when the sore looks better. Doxycycline, erythromycin base, and trimethoprim-sulfamethoxazole are the CDC-listed alternatives. Stopping early is the most common reason for relapse.
How we sourced this article: This guide synthesizes current treatment guidance from the U.S. Centers for Disease Control and Prevention, peer-reviewed clinical overviews indexed in NCBI Bookshelf, and educational summaries from Cleveland Clinic. Anecdotes and dialogue patterns have been written as composite illustrations of documented case-report timelines, not first-person testimony from named individuals. Where specific clinical numbers (dosages, durations, symptom windows) appear, the citation linked inline is the source we verified against.
- U.S. Centers for Disease Control and Prevention. Sexually Transmitted Infections Treatment Guidelines, 2021. Donovanosis (granuloma inguinale): clinical description, diagnostic recommendations, and azithromycin first-line regimen with doxycycline, erythromycin base, and trimethoprim-sulfamethoxazole as listed alternatives.
- Cleveland Clinic. Granuloma inguinale (Donovanosis): overview of presentation, geographic distribution, and treatment.
- National Center for Biotechnology Information. Donovanosis: clinical overview, microbiological diagnosis, and management. StatPearls.
- U.S. Centers for Disease Control and Prevention. Sexually Transmitted Infections Treatment Guidelines, 2021. Main landing page for current STI clinical recommendations.
- World Health Organization. Sexually transmitted infections (STIs): global fact sheet on STI prevalence, prevention, and control. Cited for general epidemiological context on the broader STI landscape in which Donovanosis sits.